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1. Introduction 
Phospholipases A2 (PLA2s) (phosphatidylcholine 2-acylhydrolases, EC 3.1.1.4) are 
ubiquitous lipolytic enzymes. PLA2s are widely spread in nature; they have been found in 
many organisms including mammals, reptiles, invertebrates, plants, fungi, ameba, bacteria, 
and viruses as well as in snake and bee venom. The PLA2s include five distinct types of 
enzymes: the secreted PLA2s (sPLA2), the cytosolic PLA2s, the Ca2+ independent PLA2s, the 
platelet-activating factor acetylhydrolases, and the lysosomal PLA2s (Schaloske  & Dennis 
2006); a new type, so-called adipose-specific PLA2, has been described recently (Duncan et 
al., 2008). PLA2s form a numerous protein superfamily, which is divided into 15 groups and 
many subgroups basing on their amino acid sequences, molecular masses, origin, number of 
disulphide bonds, Ca2+-dependence and so on. 
“Conventional” sPLA2s belonging to groups I/II/V/X are closely related, 13–19-kDa 
secreted enzymes with a highly conserved Ca2+-binding loop, a catalytic site with a His–Asp 
dyad, six absolutely conserved disulfide bonds and up to two additional unique disulfide 
bonds, which contribute to the high degree of stability of these enzymes (Murakami et al., 
2011). They require calcium at a level of extracellular environment for the lipolytic activity. 
For examples, PLA2s of group I are monomers of 13-15 kDa with 7 disulfide bridges. 
Among these, there are PLA2s of group IA found in Elapidae snake venom and those of 
group IB found mostly in mammalian pancreas. Group II of PLA2s comprises 6 sub-groups: 
sub-groups IIA and IIB are typical for Viperidae snake venom whereas sub-groups IIC-IIF 
are typical for mammalian tissues. Group III comprises sPLA2s from mammals, lizards, and 
bee venom (Schaloske  & Dennis 2006). 
Cytosolic PLA2s have no apparent homology to sPLA2s and differ from the latter in 
molecular mass, which is in the range from 60 to 115 kDa, stability to thiol reagents and 
requirement in calcium at a cytosolic level which, in contrast to the sPLA2s, is required 
rather for translocation of the enzyme to intracellular membranes than for catalysis. 
Cytosolic PLA2s utilize the Asp-Ser catalytic dyad; phosphorylation of the Ser residue 
enhances lipolytic activity (Schaloske  & Dennis 2006). These PLA2s are found only in 
vertebrates (Murakami et al., 2011). 
Ca2+-independent PLA2s are referred to so-called patatin-like phospholipase domain-
containing lipases (Murakami et al., 2011). Like cytosolic PLA2, they utilize a serine for 
catalysis (Schaloske  & Dennis 2006). 
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The main effect of PLA2 is the hydrolysis of the sn-2 position of glycerophospholipids to 
release fatty acid (as a rule, unsaturated one, especially arachidonic acid, 20:4 n–6) and 2-
lysophospholipids. The down-stream enzymes of arachidonate methabolism are 
cyclooxygenases and lipoxygenases (COXs and LOXs). Arachidonic acid is a key precursor 
of various eicosanoids including prostaglandins, thromboxanes and leukotrienes with their 
own biological activities. In addition to (or along with) lipolytic activity, PLA2s may exert a 
broad spectrum of biological effects. So, they may impact different cell functions as well as 
display pro-inflammatory, platelet-activating, cytotoxic and other stress response-inducing 
properties (see reviews (Boyanovsky & Webb, 2009; Lambeau & Gelb, 2008)) and even anti-
bacterial action (mainly of group IIA, (Buckland & Wilton, 2000; Nevalainen et al., ,2008)). 
sPLA2s from venoms may also possess anticoagulant activity, presynaptic neurotoxicity, 
myo- and cytotoxicity. The main biological activities of PLA2s from different groups along 
with their effects on PC12 cells are summarized in table 1. Some of these diverse effects 
depend on the enzymatic activity while others do not. In certain cases, e.g., affecting blood 
coagulation, some of sPLA2s need to hydrolyze phospholipids to gain an anti-coagulant 
effect while others show the anti-coagulant activity per se, without such hydrolysis (Kini, 
2005). The non-enzymatic effects may involve different mechanisms, for example, protein-
protein interactions (Hanasaki, 2004; Lambeau & Lazdunsky, 1999; Valentin & Lambeau, 
2000), which will be discussed below. 
None of known PLA2s exerts all variety of the above biological effects. To explain snake 
venom sPLA2 functional specificity, Kini and Evans (Kini, 2005; Kini & Evans, 1989) have 
proposed a so-called “target model”. According to this model, surface of a target cell or 
tissue have a “target site” (“target protein”) which is recognized by a complementary 
“pharmacological site” in the PLA2 molecule. The affinity between PLA2s and target 
proteins lies in the nanomolar range, whereas the affinity between PLA2s and 
phospholipids covers the micromolar range. Such a difference may explain why the 
interaction of venom PLA2 with target protein governs the pharmacological specificity 
(Kini, 2005). The “pharmacological site” is independent of, but sometimes overlapping with, 
the active enzymatic site. Of course, neighboring phospholipids may also contribute to the 
interaction (Kini, 2005). 
A variety of membrane and soluble proteins strongly bind sPLA2s, suggesting that the 
sPLA2 enzymes could also function as high affinity ligands (Hanasaki, 2004; Valentin & 
Lambeau, 2000). Most of the binding data have been accumulated with venom sPLA2s and 
group IB and IIA mammalian sPLA2s. In general, venom sPLA2s have been shown to bind to 
membrane and soluble mammalian proteins of the C-type lectin superfamily (M-type sPLA2 
receptor and lung surfactant proteins), to N-type receptors, to pentraxin and reticulocalbin 
proteins, and to factor Xa (see review (Valentin & Lambeau, 2000)). M-type PLA2 receptor 
has been found in muscle first (therefore – M) and then identified in other organs; the PLA2 
binding to this receptor is calcium-insensitive. N-type PLA2 receptor has been found in 
brain (N – neuronal); more recently N-type-like PLA2 receptors have been found in other 
organs. The PLA2 binding to this receptor is calcium-dependent. These receptors selectively 
bind certain sPLA2s with picomolar affinity. So, bee venom PLA2 binds to N-type and M-
type receptors with IC50 of 80 pM and >0.3 M, respectively. The affinity of OS1, a PLA2 
from taipan snake venom, for these two receptors is quite different: 34 pM for M-type and 
1.5 M for N-type, while OS2 from taipan binds these receptors with almost equal affinity (6 
and 10 pM for M- and N-type, respectively) (Lambeau & Lazdunski, 1999). Hence, some 
additional mechanism(s) besides phospholipide hydrolysis should be considered in 
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PLA2 group  Distribution Main activity(s) Effect(s) on PC12 
IA Elapidae snake venom 
Acute toxicity, cytotoxicity; 
platelet aggregation, 
anticoagulant.  
Differentiation, 
cytotoxicity. 
IB 
Pancreatic secretions, 
lung, liver, spleen, kidney, 
brain  
Digestion of dietary PLs; 
antibacterial; eicosanoid 
formation; cell contraction, 
proliferation, migration, 
pyknosis. 
 
Elapidae snake venom  Differentiation 
IIA 
Acute phase serum, 
intestinal mucosa, lacrimal 
gland cells, prostatic 
epithelial cells 
Inflammation, acute phase 
protein; antibacterial; atherogenic; 
anti-tumor or pro-tumorigenic; 
cell proliferation, migration, 
apoptosis; exocytosis and 
neurotransmitter release. 
Apoptosis; exocytosis 
and neurotransmitter 
release. 
Viperidae snake venom 
Acute toxicity, cytotoxicity, 
miotoxicity, neurotoxicity; 
platelet aggregation, 
anticoagulant. 
Differentiation; 
cytotoxicity; exocytosis 
and neurotransmitter 
release (blockage at 
internal application). 
III 
Kidney, heart, liver, 
skeletal muscle, 
epididymus, placenta, 
leukocytes 
Sperm maturation; pro-
tumorigenic; antiviral. 
Differentiation; cell 
survival. 
Bee venom 
Inflammation; cytotoxicity, 
pyknosis; antibacterial. 
Differentiation, 
cytotoxicity. 
V 
Heart, eye, lung, pancreas, 
macrophages, neutrophils, 
mastocytes 
Antibacterial, antifungal, 
antiviral; atherogenic; eicosanoid 
generation; phagocytosis. 
Differentiation. 
X 
Gastrointestinal tract, 
stomach, lung, testis, 
spleen, thymus, 
neutrophils, macrophages
Antibacterial, antiviral, 
atherogenic, pro-tumorigenic. 
Differentiation. 
XIII Bacteria/fungi 
Modulation of host inflammatory 
response. 
Differentiation. 
Cytosolic 
PLA2s 
Kidney, brain, heart, 
spleen, thyroid 
Inflammation, anaphylaxis; 
ulceration; acute lung injury, 
brain injury; parturition; 
nociception; junction proteins 
through or from the Golgi. 
Apoptosis, hypoxic or 
ischemic cell death; 
partition in exocytosis. 
Ca-
independent 
PLA2s 
Different cell types 
Cell activation, proliferation, 
migration, or apoptosis, pro-
tumorigenic; secretion; control of 
energy metabolism in adipocytes.
Apoptosis, hypoxic or 
ischemic cell death; 
regulation of exocytosis. 
Table 1. The main biological activities of PLA2s and their effects on PC12 cells. The table 
includes only those PLA2 groups that have been shown to act on/in PC12 cells. The data 
have been compiled mainly from (Boyanovsky & Webb, 2009; Farooqui, 2009; Murakami et 
al., 2011; Nakashima et al., 2003; Schaloske & Dennis 2006). 
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signaling pathways in which PLA2s take part. For example, it has been suggested that 
“neuronal” effects of sPLA2s derived from animal venoms may be mediated by their 
specific binding to N-type receptor on neuronal membranes (Hanasaki, 2004). It should be 
noted, that to date there is no direct evidence on presence of a sPLA2 receptor in PC12 cells 
(neither of C-lectin-like nor of any other type). 
There is a lot of data that PLA2s may display neurotoxic properties. They may affect also 
some important neuronal functions, such as neurotransmitter release and neuronal survival 
as well as neuritogenesis. Thus, there is no coincidence that PLA2s are found in nerve 
growth cones in PC12 cells. We do not intend to discuss here all the effects of PLA2 on 
various types of neuronal cells as it has already done in overall by others (for instance, see 
respective chapters in (Farooqui, 2009) and other reviews). In accordance with the topic of 
the present book, we shall consider in details the PLA2 effects mainly on PC12 cell line.  
2. PLA2 and neurite outgrowth in PC12 cells 
PC12 cell line has been derived from rat pheochromocytoma which is a tumor of neuronal 
origin. This cell line serves sometimes as a convenient model for studying some “neuronal” 
effects of different compounds. It is known for many years that PC12 cells are also capable 
to exhibit neurite outgrowth upon appropriate external stimulation. This process may be 
evoked by application of different biochemical agents: polypeptides (e.g., neurotrophins: 
nerve growth factor (NGF) or fibroblast growth factors, and some neuropeptides of secretin 
superfamily (e.g., PACAP) (Ravni et al., 2006; Vaudry et al., 2002)), cAMP, which seems to 
be a messenger of the latters (Gerdin & Eiden, 2007),  and its certain derivatives (Gunning et 
al., 1981), sialoglycosides (Ledden et al., 1990) and sialic acid precursors (Kontou et al., 
2009), lectins (Wu et al., 2004), some phospholipide metabolites (discussed below), calcium 
ions (by membrane depolarization), etc. Biochemical pathways converting signals from such 
diverse molecules to the neurite outgrowth may be either very different or almost identical, 
may overlap, or supplement, or amplify each other. For example, the differentiation 
pathways in PC12 are summarized in (Eiden et al., 2011). In all cases, the neurite outgrowth 
in PC12 is accompanied by shifting from a chromaffin cell-like phenotype to a neurite-
bearing sympathetic neuron-like phenotype and results in termination of proliferation. The 
sum of these events is considered as an indicator of cell differentiation (Nakashima et al., 
2004), the process opposed to malignant growth. Thus, PC12 is an excellent model to study 
at a cellular level the neuronal differentiation and antiproliferative effects of different 
compounds. In this paper we undertake the first attempt to systematize the data about 
effects of PLA2s on PC12 and to consider the possible mechanism(s) involved in these 
processes. However, we should say that PC12 cells in non-differentiated and differentiated 
forms have been documented to display at certain circumstances their own endogenous 
secretory, cytosolic, and calcium-independent PLA2 activity.  
There is a number of papers discussing a role of activation of intracellular phospoholipase C 
or phospholipase D in NGF-induced PC12 differentiation (as well as in some other cellular 
events). The effects of these enzymes will not be considered in details in the present paper. 
At the same time, increased activity of endogenous PLA2 has been found in nerve growth 
cones in differentiating PC12 and much of this PLA2 activity has been shown to be calcium-
independent and secretory rather than cytosolic (Martin, 1998) or solely secretory (Ferrini et 
al., 2010). One cannot assert, however, that the activation of endogenous PLA2 is indeed an 
initial cause of neuritogenesis. 
www.intechopen.com
 
Phospholipase A2 and Signaling Pathways in Pheochromocytoma PC12 Cells 
 
69 
Along with the above mentioned substances, exogenous sPLA2s derived from different 
sources have been also found to induce the neurite outgrowth as well as produce some other 
effects in PC12 cells. Such a “neuritogenic” property has been already reported for sPLA2s 
of groups IA and IB from cobra venom (Makarova et al., 2006; Osipov et al., 2010), IIA from 
viper venom (Makarova et al., 2006), III from bee venom (Nakashima et al., 2003) and from 
human neuronal cells (Masuda et al., 2008), V from mouse (Nakashima et al., 2003), X from 
mouse (Nakashima et al., 2003) and human (Ikeno et al., 2005; Masuda et al., 2005), as well 
as XIII from bacteria and fungi (Nakashima et al., 2003). According to the early report 
(Hanada et al., 1996), fungal PLA2 p15 promotes only NGF-induced neuritogenesis but itself 
alone fails to induce neurite outgrowth in PC12; however, under some conditions p15 can 
displays neuritogenic properties (Wakatsuki et al, 1999). The concentrations at which 
sPLA2s begin to exert the neuritogenic effect are quite different. So, sPLA2 from bee venom 
being the most active among studied sPLA2s induces neurite outgrowth at concentration as 
low as 0.1 nM. sPLA2 of group XIII is effective starting from 1 nM (Nakashima et al., 2003), 
and snake venom sPLA2s of groups IA, IB, and IIA are effective at concentrations of 1-10 
M (Makarova et al., 2006; Osipov et al., 2010). Not all of sPLA2s can induce neuritogenesis: 
for example, mammalian sPLA2s of groups I and II are unable to produce this effect 
(Nakashima et al., 2003), while PLA2s of these groups from snake venom and mammalian 
PLA2s of groups V and X are effective in inducing neurite outgrowth . 
It is assumed now that neurite outgrowth stimulated by PLA2s in PC12 cells is induced by 
the products of phospholipids hydrolysis and/or by their metabolites. Numerous data 
argue for this assumption. For instance, lysophosphatidylcholine (LPC) but not other 
lysophospholipids or arachidonic acid has been shown to promote the neurite outgrowth 
(Ikeno et al., 2005; Masuda et al., 2008). Overproduction or suppression of G2A, a G-protein-
coupled receptor involved in LPC signaling, results in the enhancement or reduction, 
respectively, of neuritogenesis induced by sPLA2 treatment (Ikeno et al., 2005). LPC (either 
exogenously added or generated in situ by sPLA2-catalysed phosphatidyl choline 
hydrolysis) acts through an L-type Ca2+ channel-dependent mechanism. No synergistic 
enhancement of both sPLA2-promoted and LPC-induced neuritogenesis is produced by the 
co-addition of 100 μM arachidonic acid (Nakashima et al., 2003). Another way for LPC 
signaling is an activation of cytosolic phospholipase D2 which is involved in the regulation 
of depolarization-induced PC12 cell differentiation through activation of tyrosine kinases 
Pyk2(Y881) and ERK (extracellular signal-regulated kinase). However, action of different 
phospholipid products on PC12 is multilateral and dependent on certain extra factors. For 
example, similarly to PLA2 docosahexaenoic acid (22:6 n–3) is present in neurite growth 
cones. This acid decreases time-course activity of cytosolic PLA2 (Martin, 1998) and 
attenuates (Kim et al., 2001) or accelerates (Schonfeld et al., 2007) apoptotic death in PC12 
cells. On the other hand arachidonic acid suppresses neurite outgrowth induced by nerve 
growth factor (Ikemoto et al., 1997) and also may be both anti-apoptotic (Kim et al., 2001) 
and pro-apoptotic at deprivation of NGF and serum (Atsumi et al., 1997) in PC12 (see also 
section 4). The above mentioned phospholipase D2 hydrolyzes the lysophospholipids with 
the formation of lysophosphatidic acid, which enhances cell proliferation. In differentiated 
PC12 cells lysophosphatidic acid provokes a rapid withdrawal of neurites (Moolenaar et al., 
2004). 
The direct relationship between the PLA2 enzymatic and differentiating activities may not 
be always evident. A number of papers (Ikeno et al., 2005; Nakashima et al., 2003; 
Nakashima et al., 2004) argues that anti-proliferative activity of PLA2s in PC12 is directly 
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related to enzymatic activity. It has been suggested (Ikeno et al., 2005) that the binding of 
bee venom sPLA2 to the putative neuronal N-type receptor (see above) unlikely to be 
involved in PLA2-induced neurite outgrowth in PC12 cells. However, the data of 
(Nakashima et al., 2003) are contradictory to these conclusions: it has been shown that in 
PC12 cells catalytically inactive mutants of sPLA2s from groups V and X in which the active 
site His has been replaced by Ala exhibit neuritogenic activity that is only two times smaller 
than that of the native forms. Therefore, the His residue in the active site only promotes but 
does not determine the neuritogenic activity of sPLA2s in PC12. Another example showing 
that phospholipid hydrolysis is not the single requirement for the neuritogenic activity is a 
sPLA2 from Egyptian cobra venom: it possesses very weak enzymatic activity but induces 
neurite outgrowth in PC12 even more efficiently than cobra venom sPLA2 with strong 
enzymatic activity (Osipov et al., 2010). 
Tumor cells of definite types can change their shape and stop proliferation being separated 
from a substrate. In whole, this is true for PC12 cells too. The possible role of extracellular 
matrix in the PLA2-induced neuritogenesis becomes evident from the following data. When 
PC12 cells are grown on polyethyleneimine used as a plate coat, fungal PLA2 p15 is unable 
to induce neurites but can only enhance the effect of NGF (Hanada et al., 1996). On the other 
hand it is known that collagen is the most effective purified extracellular matrix component 
supporting PC12 cell adhesion and NGF-induced neurite outgrowth. If the PC12 cells are 
grown on collagen-coated surface, p15 alone induces neurite outgrowth at concentration as 
low as 1 nM and does not require the addition of NGF for this effect (Wakatsuki et al, 1999). 
Moreover, the effect of p15 is faster than that of NGF: small neurites appear after 6 h of p15 
treatment versus 24 h in the case of NGF (Wakatsuki et al, 1999). 
3. Interdependent action of PLA2 and other agents 
PC12 cells express sodium, potassium, and calcium ion channels and receptors for a lot of 
different ligands (grouth factors, neurotransmitters, adenosine and so on); effects of all these 
membrane proteins are in strong interdependence. At the first place, there are receptors for 
growth factors. There are two classes of receptors for NGF on cell surface: high affinity 
TrkA, a receptor tyrosine kinase which is highly specific for NGF, and a low affinity p75 
neurotrophin receptor which binds all members of the neurotrophin family with a similar 
affinity (Skaper, 2008). Activation of p75 results in apoptosis of PC12 cells while activation 
of TrkA results in their differentiation. There is one intriguing and so far unexplained 
observation that NGF and several other agents are mitogens for normal chromaffin cells, but 
are anti-proliferative agents and induce neuronal differentiation of PC12 cells (Tischler et al., 
2004). It should be mentioned that NGF induces an activation of the Na+, K+-pump in PC12 
cells and increases sodium influx. Moreover, some researchers have seen small changes in 
cAMP level and in calcium currents evoked by NGF while others have not. 
In PC12 cells NGF increases mRNA level for cytosolic PLA2 after treatment for 4h and 
cytosolic PLA2 protein level at 24h after beginning of treatment via the ERK1/2, p38 MAPK 
and PKC pathways (Akiyama et al, 2004). The following data support synergism in PLA2 
and NGF action (Masuda et al., 2008). Adenoviral expression of human sPLA2 of group III 
(PLA2-III) in PC12 cells or dorsal root ganglion explants facilitates neurite outgrowth, 
whereas expression of a catalytically inactive PLA2-III mutant or use of PLA2-III-directed 
small interfering RNA (siRNA) reduces NGF-induced neuritogenesis. The results of the 
experiment with siRNA suggest that endogenous sPLA2-III profoundly affects 
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neuritogenesis of PC12 cells. PLA2-III also suppresses neuronal death induced by NGF 
deprivation. In principle, this work (Masuda et al., 2008) demonstrates that the effects of 
NGF and PLA2 are different, however they complement each other. Thus, the 
overexpression of PLA2 replaces NGF, while NGF is not effective if PLA2 is switch off. 
The data on blockage of PC12 differentiation evoked either by NGF or by PLA2 indicate that 
different pathways are involved in effects of these two agents. Thus, tyrosine kinase 
inhibitor K-252a blocks differentiation induced by NGF. Unlike NGF, neuritogenesis 
induced by sPLA2s is insensitive to K-252a. In contrary, inhibition of L-type calcium channel 
or depletion of extracellular calcium, which are ineffective in blocking NGF-induced 
neuritogenesis, may inhibit sPLA2-induced neurite outgrowth (Wakatsuki et al., 1999). 
On the other hand, NGF activates not only tyrosine kinase cascade but also phospholipases 
C and A2 which in turn results in enhance of arachidonate release from the cell lipids 
(Tsukada et al., 1994). Phosphorylation in vitro and in vivo of cytosolic PLA2 by mitogen-
activated protein kinase at Ser505 increases its intrinsic enzyme activity several fold (Lin et 
al., 1993). After NGF treatment, the PLA2 activity in the PC12 cell lysate increases 4-fold on 
the third day (Ferrini et al., 2010) and during 7 days increases approximately 1.5-fold 
(Matsuzawa et al., 1996) i.e., effects of NGF and PLA2 on PC12 cells are mediated by 
different but somehow related mechanism(s). NGF changes the subcellular localization of 
group IIa endogenous sPLA2 in PC12 cells. In untreated cells, this PLA2 is mainly cytosolic 
and mitochondrial in localization. As soon as 6 h after NGF stimulation, it is no longer 
associated with mitochondria being found diffusely in the cytoplasm and associated with 
the plasma membrane as well as in growth cones at specific membrane domains. After 24 h, 
IIA PLA2 is detected within neurites and, at longer periods, the enzyme is mostly localized 
at neurite tips of neuron-like differentiated cells, as determined by confocal laser 
immunofluorescence microscopy analysis using anti-rat group IIA PLA2 monoclonal 
antibody (Ferrini et al., 2010). After treatment with NGF under identical conditions, group V 
PLA2 retains its cytoplasmic and nuclear localization and is scarcely present within neurites 
and neurite tips. 
PC12 cells themselves comprise enzymes for synthesis of both catecholamines and 
acetylcholine. At the same time they bear acetylcholine receptors of both nicotinic and 
muscarinic types; stimulation of the formers results in the release of catecholamines while 
stimulation of the latter results in calcium influx and phosphoinositide hydrolysis (Fujita et 
al., 1989). 
Calcium ion influx through voltage-gated channels triggers a variety of cellular events 
leading to neurite outgrowth via the concerted action of various calcium-binding proteins. 
Calcium influx mediates induction of gene expression in response to membrane 
depolarization. In PC12 cells, L-type channels are the primary carrier of voltage-sensitive 
calcium currents and have been shown to be required for sPLA2-induced neuritogenesis 
(Nakashima et al., 2003). The calcium signal transduction pathway promoting neurite 
outgrowth causes the rapid activation of protein tyrosine kinases, which include MEK1 and 
Src. They, in turn, further activate Ras (small guanine nucleotide-binding protein) and MAP 
kinase. A set of stimuli evokes the calcium influx; simultaneously cytosolic PLA2s are 
activated which results in release of arachidonic acid and other products of phospholipid 
hydrolysis. Interestingly, such a calcium-dependent activation of the cytosolic PLA2 does 
not need the extracellular calcium, and calcium from intracellular stores would be enough. 
Activation of an exogenous sPLA2 (either applied externally or expressed in PC12 cells) 
requires an influx of extracellular calcium. Thus, sub-millimolar and sub-micromolar Ca2+ 
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concentrations are necessary for activation of secretory and cytosolic PLA2s, respectively 
(Matsuzawa et al., 1996). Similarly to calcium as well as NGF pathways (Rusanescu et al., 
1995; Vaudry et al., 2002), the sPLA2-induced neuritogenesis in PC12 involves the activation 
of Src and Ras proteins and is accompanied by the activation of MAPK cascade (Wakatsuki 
et al., 1999). The existing data indicate that PLA2, NGF, and calcium ions can act 
independently but synergistically in PC12 cells. However, as all of them activate the 
Ras/MAPK cascade, it is reasonable to suggest that their signaling pathways partially 
overlap. 
Endogenous PLA2s in PC12 can be activated by different damaging agents (cyanides, 
reactive oxygen species, some cytolysins, etc.) that results in release arachidonic acid and its 
metabolites. Arachidonic acid being released by diacylglycerol hydrolysis promotes the 
opening of L- and/or N-type calcium channels that may lead to neurite outgrowth. 
Furthermore, the direct addition of arachidonic acid to the culture medium stimulates 
neurite outgrowth when PC12 cells grow on a fibroblast monolayer. However, arachidonic 
acid does not increase the steady-state calcium levels in neuronal growth cones (Nakashima 
et al., 2003, as cited in Walsh & Doherty, 1997). From existing data it is still not obvious, 
whether one of the activation pathway induced by either PLA2 or calcium channels begins 
first and then evokes other one. 
Besides NGF receptor, PC12 express also two classes of epidermal growth factor receptors 
(activation of which in contrast to NGF receptor results in enhancement of PC12 
proliferation, (Vaudry et al., 2002)) and receptors for fibroblast growth factor. To our 
knowledge, there are no data published on any cross-interaction of these receptors and 
PLA2. 
Thus, PLA2s induce different cellular responses via very complex biochemical pathways in 
which PLA2s themselves or products of their enzymatic activity interact with various 
substances. These interactions are shown in a simplified form in Fig.1. 
4. PLA2 in apoptosis and cytotoxicity 
There are a lot of reports on the cytotoxic property of sPLA2s. This property is mostly 
attributable to PLA2s from animal venom. Concerning cytotoxicity of PLA2 in respect to 
PC12, it should be mentioned that sPLA2s from bee venom at concentrations higher than 10 
nM (Nakashima et al., 2003), and from cobra and viper venoms at concentrations 10 M and 
higher (Makarova et al., 2006) are toxic for these cells (i.e., induce the necrotic changes). 
Thus, cytotoxicity of many venom PLA2s attenuates strongly their “therapeutic” potential 
for differentiating action (section 2). However, non-cytotoxic sPLA2s (e.g., mammalian 
sPLA2s of groups V, X, and fungal/bacterial XIII (Nakashima et al., 2003), as well as a non-
cytotoxic variant of venom sPLA2 (Osipov et al., 2010)) still preserve this potential and can 
be regarded antiproliferative agents.  
Some toxic agents (for examples, reactive oxygen species produced by cyanides 
(Kanthasamy et al., 1997), by hydrogen peroxide (Akiyama et al., 2005), and so on) require 
cytosolic PLA2 activity for their damaging action. 
A mechanism of endogenous sPLA2 cytotoxicity remains unknown yet. Sometimes, 
researchers assign it to enzymatic activity and to released arachidonate. In several cases 
such correlation may be traced, indeed. For instances, arachidonic acid itself being added to 
PC12 in concentrations above 10 M kills the cells within 1-2 hours and does not require 
extracellular Ca2+ for the toxic effect. The removal of extracellular Ca2+ dramatically 
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Fig. 1. Scheme of PLA2 interactions with the various substances mentioned in the text. The 
key players are in the ellipses; the processes considered are italicized. Inhibiting effects are 
indicated by minus, stimulating effects – by plus. DAG is diacylglycerol, PL is a phospho-
lipide, lyso-PA is lyso-phosphatidic acid, and PLC and PLD are phospholipases C and D, 
respectively. 
accelerates the acute cell death (Doroshenko & Doroshenko, 2004). Cytolysins impair ionic 
permeability of cell membrane, leading to cell death. Several different cytolysins have been 
tested on PC12 cells and found to enhance PLA2 activity as well as levels both of 
arachidonic acid and certain its metabolites (Raya et al., 1993). Peroxynitrite-dependent 
release of arachidonate by sPLA2 is supposed to be casually linked to peroxynitrite-
dependent induction of DNA cleavage and toxicity (Guidarelli et al., 2000). However, there 
are enough reports (including cited in this paper) on PLA2s which possess high enzymatic 
activity and devoid of apparent cytotoxicity. Moreover, several papers describe the role of 
arachidonate in programmed cell death (apoptosis) but not in acute cytotoxicity. 
PC12 may undergo apoptotic cell death under some stimuli (for example, under NGF 
deprivation or by activating p75 NGF receptor). PLA2s have been shown to take part in this 
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process and extracellular Ca2+-dependent release of arachidonic acid by sPLA2 is considered 
to mediate their action (Atsumi et al., 1997). Association of sPLA2 with cell surface 
proteoglycan, which has been shown to be a prerequisite for endogenous sPLA2-dependent 
arachidonic acid release from the plasma membranes of live cells, is not essential for sPLA2-
mediated hydrolysis of apoptotic cell membranes. The authors give evidences that the 
apoptotic cell membrane is a potential target for extracellular type II sPLA2 (Atsumi et al., 
1997). Arachidonic acid, a signaling lipid potentially associated with tumor necrosis factor 
receptor-I signal cascade, induces apoptosis in PC12 cells through inhibition of both protein 
kinase C zeta and nuclear factor kappaB activity. Apoptosis induced by arachidonate cannot 
be prevented by NGF (Macdonald et al., 1999). 
Controversially, arachidonic acid has been reported to prevent neuronal apoptosis during 
serum starvation and COX and LOX do not participate in this process (Kim et al., 2001). 
Another research group has reported that arachidonic acid shows normal survival of NGF-
differentiated PC12 whereas stearic acid and palmitic acid induce apoptotic cell death 
(Ulloth et al., 2003). 
Several compounds have been reported to induce apoptosis in PC12 cells and in many cases 
PLA2 activity appears to be essential. For examples, short- and long-chain sphingosines are 
mediators of many cellular events including apoptosis in both naïve and NGF-differentiated 
PC12 (Posse de Chaves, 2006). C2-Ceramide (N-acetyl-D-erythro-sphingosine) alone 
stimulates arachidonic acid release and enhances the ionomycin-induced release. In 
contract, some sphingosines show an opposite effect and directly inhibite cytosolic 
phospholipase A2alpha activity (Nakamura et al., 2004). Nitric oxide can induce apoptosis. 
Nitric oxide is involved in the regulation of cytosolic PLA2, its phosphorylation and activity, 
arachidonic acid release and as consequence in up-regulation of expression and activity of 
COXs and LOXs; blockage of their activity may rescue cell death (Pytlowany et al., 2008). In 
neuronal PC12 cells, TNF-alpha induces moderate apoptosis. Application of TNF-alpha to 
the PC12 cells results in p38 MAPK phosphorylation and activation. Phosphorylation of p38 
MAPK is regulated by cytosolic PLA2, which produces arachidonic acid. The results present 
one possible mechanism for enhancing the neuronal cell death by arachidonate through the 
regulation of p38 MAPK. However, how arachidonate attenuates the phosphorylation of 
p38 MAPK is unknown (Park et al., 2002).  
Ortho-substituted polychlorinated biphenyls induce apoptosis in PC12. These compounds 
evoke PLA2-mediated Ca2+ influx. However, in the presence of extracellular Ca2+, PLA2 
activation is inhibited by neither an extracellular nor an intracellular Ca2+ chelator but is 
depressed by inhibitors of calcium-independent PLA2 (Shin et al., 2002). 
Along apoptosis, PC12 cells may undergo hypoxic or ischemic caspase-independent cell 
death characterized by nuclear shrinkage (pyknosis). This process comes with participation 
of calcium-independent PLA2 and, to a lesser extension, cytosolic PLA2. Interestingly, bee 
venom PLA2 and porcine pancreatic sPLA2 also can cause nuclear shrinkage in another cell 
type. Neither arachidonate nor other fatty acids (stearic, linoleic, palmitic, and oleic acids) 
induces the shrinkage suggesting that PLA2 induces nuclear shrinkage itself and that its 
metabolites are ineffective (Shinzawa & Tsujimoto, 2003). 
Thus, calcium-independent PLA2 seems to play an important role in programmed cell death 
in PC12 that is consistent with the data on participation of group VIA calcium-independent 
PLA2 in apoptosis in cell types other than PC12 (Balsinde et al., 2006; Lei et al., 2010). 
Cytosolic PLA2 also seems to participate in apoptosis. 
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Nevertheless, it is not quite understood yet why a PLA2 activity in PC12 results in cell 
necrosis in several cases, in apoptosis in some cases, and in differentiation in other.  
5. Exocytosis and secretion in PC12 cells and PLA2 
As PC12 cells are tumor scions of neuroendocrine chromaffin cells, it is relevant to mention 
the PLA2 action on catecholamine secretion in the chromaffin cells. Pre-synaptic neurotoxic 
snake venom sPLA2, taipoxin, enhances exocytosis in bovine chromaffin cells in response to 
depolarizing stimuli. It entries into the cytosol, that is already detectable after 5 min and is 
independent on extracellular calcium, i.e., the toxin does not use calcium-dependent 
endocytosis to reach the chromaffin cell cytoplasm. After 1 h, a large portion of the toxin has 
redistributed to the plasma membrane and fragmentation of the F-actin cytoskeleton is 
observed; an increased number of events of granule fusion takes place during the initial 
phase of secretion with an enhancement of the initial rate of release, and after 1 day, cell 
death becomes evident (Neco et al., 2003). Authors (Giner et al., 2007) propose mechanism 
according to which, in neuroendocrine chromaffin cells, neurotoxic sPLA2s bind to surface 
membrane receptors and hydrolyze phospholipids that results in release of 
lysophosphatidic acid among other products. This product activates intracellular pathways 
involving the glycogen synthase kinase 3 (GSK-3), an important modulator of many 
physiological processes, such as neurodevelopment, the cell cycle, apoptosis and 
oncogenesis (either as a suppressor or as a promoter) (Mishra, 2010), causing cytoskeleton 
alterations with neurite retraction. Alterations in actin cytoskeleton result in the loosening of 
the peripheral cortex barrier thus facilitating the access of secretory granules to the release 
sites of the plasmalemma (Giner et al., 2007). 
There is a lot of indications on the participation of PLA2s in exocytosis in PC12. On the one 
hand, PLA2 may participate in regulation of cell secretion; on the other hand, sPLA2 itself 
may be released by exocytosis. sPLA2 of group II is involved in the regulation of 
neurotransmitter secretion by PC12 cells. The neurotransmitters released from PC12 cells by 
PLA2 are catecholamines and acetylcholine. PLA2 seems to be involved also in the 
degranulation process in neuronal cells and itself may influence exocytosis in PC12 cells. 
External application of group IIA sPLA2 (purified crotoxin subunit B from snake venom or 
purified human synovial sPLA2) causes an immediate increase in exocytosis and 
neurotransmitter release in PC12 cells, detected by carbon fiber electrodes placed near the 
cells, or by changes in membrane capacitance of the cells. There is an indication that the 
effect of sPLA2 is dependent on calcium and sPLA2 enzymatic activity (Wei et al., 2003). 
When type II sPLA2 purified from rat platelets is added to NGF-treated PC12 cells, there is a 
dose-dependent release of both noradrenaline and dopamine, reaching a maximum release 
of ~10% at 20-40 g/ml sPLA2 after 10-30 min of incubation. Release of dopamine by 
exogenous sPLA2 is dependent on extracellular calcium. Interestingly, thielocin A1, a type II 
sPLA2-specific inhibitor, or neutralizing antibody against type II sPLA2 suppress 
noradrenaline release in a dose-dependent manner. These results indicate that endogenous 
sPLA2 may be involved in catecholamine secretion from PC12 cells. The concentration of 
exogenous type II sPLA2 required for catecholamine secretion from PC12 cells is higher than 
that which can be released from activated PC12 cells (Matsuzawa et al., 1996). Secretion of 
dopamine from PC12 cells that is stimulated by glutamate is suppressed by type II sPLA2 
inhibitors. Exogenous type II sPLA2 added alone directly elicites release of dopamine from 
PC12 cells (Kudo et al., 1996). Because the antibody could not pass through the plasma 
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membrane without permeabilization, it is likely that sPLA2 might act from outside the cells, 
becoming accessible to the antibody after cell activation. This is supported by the fact that 
exogenously added sPLA2 directly elicites dopamine release from PC12 cells in an 
extracellular Ca2+-dependent manner (Matsuzawa et al., 1996). 
In contrast to external application, internal application of sPLA2 to PC12 cells produces 
blockade of neurotransmitter release (Wei et al., 2003). 
It was suggested (Matsuzawa et al., 1996) that arachidonic acid metabolism elicited by 
neurotransmitters or by depolarization, which mobilizes intracellular Ca2+, is more likely to 
be regulated by cytosolic PLA2. However, the authors do not rule out the possibility for 
hydrolysis of membrane phospholipids by sPLA2 to liberate arachidonic acid, which leads 
to catecholamine secretion. Arachidonic acid may be released from PC12 cells in response to 
different stimuli. Thus, it is released from undifferentiated PC12 under NGF action 
(Tsukada et al., 1994). PLA2 also promotes release of arachidonate from NGF-differentiated 
PC12 cells which are stimulated, for examples, by staphylococcal alpha-toxin at subcytotoxic 
concentrations (Fink et al., 1989), peroxynitrite (by activation of endogenous sPLA2) 
(Guidarelli et al., 2000), high K+ or via direct stimulation of phospholipide hydrolysis by 
mastoparan, a tetradecapeptide PLA2 activator from bee venom (Ray et al., 1999). Several 
other compounds including orthovanadate, phenylarsine oxide, pardaxin, anandamide and 
capsaicin have been reported to induce the arachidonate releasing by PLA2 from PC12 
treated with NGF, with subsequent prostaglandin F2alpha formation. Orthovanadate 
activates cytosolic PLA2 to release arachidonate, stimulates tyrosine phosphorylation in 
proteins and enhances Ca2+-induced noradrenaline release (Mori et al., 2001). Phenylarsine 
oxide acts probably via activation of endogenous secretory PLA2; it may act synergistically 
with exogenous sPLA2 from bee venom (Ohsawa et al., 2002). Pardaxin, an -helical 
cytolysin from the fish Pardachirus marmoratus, aggregates in the plasma membrane to form 
ionic channels, followed by calcium influx. By this way it activates calcium-dependent 
PLA2, but it also can activate calcium-independent PLA2 in PC12 (Abu-Raya et al., 1998). 
Anandamide and capsaicin stimulate arachidonic acid release even in the absence of 
extracellular calcium. The effects of anandamide and capsaicin are inhibited by PLA2 
inhibitors, but not by an antagonist for vanilloid VR1 receptor (Someya et al., 2002). 
Exocytosis in PC12 may be evoked also by lysophosphatidylinositol, another product of 
phospholipid hydrolysis by sPLA2 (Ma et al., 2010). 
Arachidonate release is associated with acetylcholine release in NGF-differentiated PC12 
cells. Botulinum neurotoxin type A (BoTx) inhibits this process. K+-stimulated acetylcholine 
release is also totally inhibited by pretreatment of cells with BoTx (2 nM). Inclusion of 
exogenous arachidonate, or the PLA2 activator melittin, or bee venom sPLA2 itself prevents 
the effect of BoTx (Ray et al., 1993). Treatment of differentiated PC12 cells with mastoparan 
and high (80 mM) K+ induces acetylcholine exocytosis. The acetylcholine release depends 
upon Ca2+ influx via the N-type voltage-sensitive Ca2+ channels. The release is followed by a 
rise in intracellular free Ca2+ concentration; the increased Ca2+ activates PLA2 and, thereby, 
increases the arachidonate level (Ray et al., 1999). BoTx cleaves SNAP-25, a conserved 
synaptosomal protein essential for vesicle fusion and docking during neuroexocytosis. 
Blockage of SNAP-25 function by the antisense oligonucleotides has shown that the 
neuroexocytosis involving PLA2 activity proceeds without participation of this protein. 
Moreover, mastoparan prevents the neurotoxic effect of BoTx through induction PLA2 
activity that seems not to involve SNAP-25 pathway (Ray et al., 1999). 
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Differentiated PC12 cells, being stimulated with carbamylcholine, potassium, or glutamate, 
release sPLA2 into the medium. Thus, sPLA2 of group II is released in response to 
stimulation by neurotransmitters or depolarization. sPLA2 is released from neuronally 
differentiated PC12 cells upon stimulation by carbamylcholine via acetylcholine receptors or 
by high K+ via voltage-dependent Ca2+ channels through membrane depolarization 
(Matsuzawa et al., 1996). When NGF-treated PC12 cells are activated with glutamate, 
approximately 40% of their group II sPLA2 is released into the extracellular medium. 
Glutamate-stimulated secretion of dopamine from PC12 cells is PLA2-dependent, as it is 
suppressed by group II sPLA2 inhibitors (Kudo et al., 1996). 
As after activation of PC12 cells by carbamylcholine, the time courses of  noradrenaline and 
sPLA2 release are not parallel (the release of noradrenaline reaches a plateau at 10 min and 
that of sPLA2 at 15 min), sPLA2 and catecholamine may be stored in different secretory 
granules (Matsuzawa et al., 1996). 
A recent report has appeared concerning a role of calcium independent PLA2 in exocytosis 
and mitochondrial function in PC12: inhibition of this type of PLA2 results in excessive 
exocytosis through increased oxidative damage (or failure to repair such damage) and 
defects in mitochondrial function (Ma et al., 2011). 
It is still unclear, however, whether the relation between neurotransmitter signaling/release 
and the effects of PLA2 plays a significant role in other discussed processes including the 
PC12 differentiation. 
6. Conclusion 
In general, PLA2s are involved in different signaling pathways in PC12 cells. Various types of 
PLA2s and even groups within types may exert diverse effects on the cells. Most of them in 
one or another way are now associated with phospholipid products. One should note, 
however, that it would not be correct to attribute such diversity of effects to enzymatic activity 
of PLA2 only. Understanding the mechanisms involved in PC12 differentiation induced by 
PLA2s may results in development of new drugs inhibiting tumor cell proliferation.  
As it has been discussed in this paper, PLA2 enzymes manifest a number of very diverse 
biological properties. At the same time, PC12 cell line is a valuable model for study of 
different signaling mechanisms. The effects of PLA2s on PC12 cells are quite complex and 
multifaceted. Several striking findings have already been made upon investigation of these 
effects and one can expect further exciting findings in this area. 
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